You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 8, August 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Uveal Effusion and Secondary Angle-Closure Glaucoma Associated With Topiramate Use

Arch Ophthalmol. 2001;119:1210-1211.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Rarely, drugs, mostly sulfa-related compounds, have produced uveal effusions, forward rotation of the iris-lens diaphragm, transient myopia, and secondary angle closure.1 We have recently encountered 2 cases in which uveal effusions have occurred after administration of topiramate (Topamax; Ortho-McNeil Pharmaceutical, Raritan, NJ), a new anticonvulsant medication.

Report of Cases

Case 1

A 34-year-old white woman was seen in our emergency department with severe headaches and progressively blurry vision in both eyes. Her medical history was notable for depression. Her ocular history was unremarkable, she had never worn glasses, and she denied ocular disease within the family. Her medications included clonazepam, buspirone hydrochloride, citalopram hydrobromide, orlistat, fluvoxamine maleate (a selective serotonin reuptake inhibitor [SSRI], which she started 2 days prior to initial examination), and topiramate (which she started 2 weeks prior to initial examination).

On examination her visual acuity was 20/250 OU. Slitlamp examination revealed trace conjunctival injection and chemosis, relatively clear corneas, and shallow anterior . . . [Full Text of this Article]

Case 2


Comment
Corresponding author: Cynthia L. Grosskreutz, MD, PhD, Department of Ophthalmology, Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114-3096.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genomic Promise: Personalized Medicine for Ophthalmology
Wiggs
Arch Ophthalmol 2008;126:422-423.
FULL TEXT  

Bilateral acute angle closure secondary to uveal effusions associated with flucloxacillin and carbamazepine
Chan et al.
Br. J. Ophthalmol. 2008;92:428-430.
FULL TEXT  

Acute myopia and angle-closure glaucoma induced by topiramate
Boentert et al.
Neurology 2003;61:1306-1306.
FULL TEXT  

Topiramate induced myopic shift and angle closure glaucoma
Chen et al.
Br. J. Ophthalmol. 2003;87:648-649.
FULL TEXT  

Oligohydrosis and Hyperthermia: Pilot Study of a Novel Topiramate Adverse Effect
Ben-Zeev et al.
J Child Neurol 2003;18:254-257.
ABSTRACT  

Angle-Closure Glaucoma Associated With Ciliary Body Detachment in Patients Using Topiramate
Medeiros et al.
Arch Ophthalmol 2003;121:282-285.
FULL TEXT  

Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression
Rapaport and Hales
Focus 2003;1:15-31.
ABSTRACT | FULL TEXT  

Ciliochoroidal Effusion Syndrome Induced by Sulfa Derivatives
Ikeda et al.
Arch Ophthalmol 2002;120:1775-1775.
FULL TEXT  

Topiramate-Associated Secondary Angle-Closure Glaucoma: A Case Series
Thambi et al.
Arch Ophthalmol 2002;120:1108-1108.
FULL TEXT  

Drug induced acute myopia with supraciliary choroidal effusion in a patient with Wegener's granulomatosis
Ramos-Esteban et al.
Br. J. Ophthalmol. 2002;86 :594-596.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.